2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
61
Genitourinary
12
Gastrointestinal
11
CNS
11
Thoracic
9
NET
8
Head & Neck
8
Sarcoma
7
Gynecologic
7
Breast
6
Dermatologic
4
Other solid neoplasm
2
Other hematologic neoplasm
2
Plasma cell
1
Other
1
Myeloid
1
Lymphoid
1
Conditions
Lymphoma
2983
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2499
Lymphoma, Non-Hodgkin
2269
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Lymphoma, Follicular
1848
Lymphoma, Large B-Cell, Diffuse
1785
Leukemia
1341
Hodgkin Disease
1293
Lymphoma, Mantle-Cell
1193
Leukemia, Myeloid, Acute
979
Burkitt Lymphoma
956
Multiple Myeloma
866
Lymphoma, B-Cell, Marginal Zone
853
Recurrence
841
Lymphoma, B-Cell
756
Myelodysplastic Syndromes
683
Neoplasms
595
Lymphoma, T-Cell, Cutaneous
543
Waldenstrom Macroglobulinemia
514
Lymphoma, Large-Cell, Immunoblastic
490
Mycosis Fungoides
438
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
414
Lymphoma, Large-Cell, Anaplastic
390
Sezary Syndrome
364
Lymphoma, T-Cell, Peripheral
352
Hematologic Neoplasms
351
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
334
Myeloproliferative Disorders
328
Neoplasms, Plasma Cell
309
Blast Crisis
284
Interventions
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Drug Therapy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adrenal Gland Neoplasms
×
Lymphoid
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled